CN1099835C - Antilipemic beverage or tea - Google Patents
Antilipemic beverage or tea Download PDFInfo
- Publication number
- CN1099835C CN1099835C CN00129714A CN00129714A CN1099835C CN 1099835 C CN1099835 C CN 1099835C CN 00129714 A CN00129714 A CN 00129714A CN 00129714 A CN00129714 A CN 00129714A CN 1099835 C CN1099835 C CN 1099835C
- Authority
- CN
- China
- Prior art keywords
- present
- blood
- tea
- salviae miltiorrhizae
- polygoni multiflori
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to an antilipemic beverage or tea. The present invention is characterized in that one portion of barbary wolfberry fruits, one portion of pleuropterus cordatus, one portion of hawthorn, one portion of solomonseal rhizome, one portion of red sage roots and one portion of oriental waterplantain rhizome are ground into powder as medicinal tea which is infused by boiling water for drinking, or are mixed together and decocted by water for taking. The present invention has the functions of nourishing the liver and the kidney, dispersing blood clots, dredging the meridian passage, reducing blood fat and blood pressure, relieving flatulence and reducing weight. The present invention can be drunk regularly for a long time, and has no toxic side effects.
Description
Technical field
The present invention relates to have the medicament of blood fat reducing effect, refer to a kind of Antilipemic beverage or tea of making by Chinese herbal medicine especially.
Background technology
Hyperlipidemia is a kind of systemic disease that increases based on blood fat, can change and metabolic disorder with the pathologic of organ pipes such as blood vessel, the heart, brain, kidney, as complication such as the common hypertension that causes by hyperlipidemia, atherosclerosis, fatty liver, coronary heart disease, diabetes, cerebral thrombosis, obesity, obese type edema clinically.This sick sickness rate height, complication is many, is more and more seriously threatening the healthy of people, but present clinical specially good effect control medicine that this is not still had.
The inventor is according to the clinical practice in surplus nearly 40 years and deep theoretical knowledge, executes so that motherland's medical science is dialectical that to control be principle, works out blood fat reducing side of the present invention medicine " Antilipemic beverage " or " tea ", and clinic trial is all received good the effect.
Summary of the invention
Promptly the purpose of this invention is to provide a kind of Antilipemic beverage or tea of being made by Chinese herbal medicine, it has the function of nourishing the liver and kidney, removing blood stasis with potent drugs collateral dredging, blood fat-reducing blood pressure-decreasing, relieving distension fat-reducing, but long-term drink has no side effect.
Antilipemic beverage of the present invention is a decocting liquid of getting each portion of Fructus Lycii, the Radix Polygoni Multiflori, Fructus Crataegi, Rhizoma Polygonati, Radix Salviae Miltiorrhizae and Rhizoma Alismatis gained behind decocting.
Wherein again with Fructus Lycii 15g, Radix Polygoni Multiflori 15g, Fructus Crataegi 15g, Rhizoma Polygonati 15g, Radix Salviae Miltiorrhizae 15g and Rhizoma Alismatis 15g, with slow fire decocting three times, one fried in shallow oil 40 minutes, two fried in shallow oil 30 minutes, three fried in shallow oil 15 minutes, three fry in shallow oil and convert about together 1000ml, and it is good being concentrated into the made drink liquid in the 250ml left and right sides, and this dosage just in time is the dose of a bu three times.
The present invention is as making antihyperlipemic tea, by forming by being ground into each a mixing of powdered Fructus Lycii, the Radix Polygoni Multiflori, Fructus Crataegi, Rhizoma Polygonati, Radix Salviae Miltiorrhizae and Rhizoma Alismatis.
It is good wherein containing Fructus Lycii 15g, Radix Polygoni Multiflori 15g, Fructus Crataegi 15g, Rhizoma Polygonati 15g, Radix Salviae Miltiorrhizae 15g and Rhizoma Alismatis 15g with every dose again.Brew with boiling water when taking, in one day for tea-drinking.
Taking the present invention was the course of treatment with one month generally, needed logotype two to three months.
Control from theory of Chinese medical science analysis prescription mechanism of the present invention and dialectical executing below
Hyperlipidemia, according to theory of Chinese medical science, its basic pathogenesis is an imbalance of YIN and YANG, the hepatic and renal YIN deficiency, deficiency of nutrient QI and blood, hematogenous blockage.The rule of treatment needs yin and blood nourishing, blood stasis dispelling to promote blood circulation.The present invention is a principal agent with the Radix Polygoni Multiflori, Rhizoma Polygonati, Fructus Lycii, with the liver and the kidney tonifying, nourish Kidney-Yin.Radix Salviae Miltiorrhizae, " kind control blood system, the tissue regeneration promoting that goes to stagnate, regulating menstruation are along the master of arteries and veins also." " book on Chinese herbal medicine converges and says "; Fructus Crataegi, " grease that can disappear long-pending " (" explaining abstruseness of the canon of materia medica "), and " if help it with sweet medicine, blood stasis dispelling blood and do not hinder fresh blood (" ginseng is gone through record in the medical science inner feelings ").Two medicines are adjuvant drug altogether, close gathering the merit of the logical stasis of blood of stagnating.Use Rhizoma Alismatis, " diuresis heat clearing away and non-impairment of YIN ", the disease of yang hyperactivity with the system deficiency of YIN.All medicine compatibilities can be for gathering the effect that trophema the moon, blood stasis dispelling promotes blood circulation.
Again from pharmacology analysis composition principle of the present invention: at first need explanation, though the present invention is for the theory of Chinese medical science being the pure Chinese medicine formula that basis is discussed and formulated, but study carefully its pharmacology, conform to modern pharmacology and to be harmonious, modern pharmacology confirms, the contained lecithin of Radix Polygoni Multiflori Preparata can promote the erythrocyte growth promoter, stops cholesterol at intrahepatic deposition, stops lipoids to infiltrate into tunica intima." Chinese medicine voluminous dictionary " reports that also it " can reduce serum ornitrol " and have " effect for reducing fat ".Fructus Lycii, its aqueous solution have slight inhibition fat to deposit in hepatocyte, promote hepatocyte new life's effect, and can cholesterol reducing, can slightly stop the formation of experimental atherosclerosis.
Rhizoma Polygonati can reduce the blood pressure of anesthetized animal, and it is too high to suppress the blood glucose that epinephrine causes, prevent infiltration atherosis and that liver is fatty, and three flavor medicines all has blood sugar decreasing effect in various degree.Radix Salviae Miltiorrhizae, it can treat coronary heart disease according to " Chinese medicine voluminous dictionary " and clinical report; Radix Salviae Miltiorrhizae Injection can make part patient cholesterol descend.Fructus Crataegi, its contained lipolytic enzyme of modern Chinese medicine theoretical validation can promote the digestion of fat food, the expansible blood vessel of water extract, coronary blood flow increasing, and make blood pressure drops, and ethanol extract energy cholesterol reducing, Crataegolic acid also has cardiotonic.It reduces the serum ornitrol effect certainly " Chinese medicine voluminous dictionary " clinical report.Rhizoma Alismatis, its extract has preventive and therapeutic effect to experimental hyperlipidemia, and serum total cholesterol and content of triglyceride are reduced, and the fatty liver due to low protein diet and the ethionine is had in various degree inhibitory action.So all medicines share, absorption, decomposition and the drainage of energy vessel softening, promotion blood fat, and can make the lipid dissolving that is deposited on blood vessel wall, thus reach blood fat reducing, the curative effect of clear sharp blood vessel.Other complication also can alleviate thereupon or eliminate simultaneously.
The inventor once did clinical trial with Antilipemic beverage or tea of the present invention, observe 63 routine hyperlipidemias, after taking one month, blood fat all has reduction in various degree, symptoms such as and blood pressure, cholesterol, beta Lipoprotein, triglyceride also descend thereupon, can drop to normal range mostly after two months, and dizzy, uncomfortable in chest, asthma, numb limbs and tense tendons, women's idiopathic edema, fat are fat also can disappear thereupon or obviously alleviate, for consolidating curative effect, can continue to obey one month.This drink liquid also can be used as health product and takes in 1 hour after meal low dose, can make the lipid in the diet obtain dissolving and drainage at once, in case store up in vivo.
The specific embodiment
Get Fructus Lycii 15g, Radix Polygoni Multiflori 15g, Fructus Crataegi 15g, Rhizoma Polygonati 15g, Radix Salviae Miltiorrhizae 15g, Rhizoma Alismatis 15g, with slow fire decocting three times, one fried in shallow oil 40 minutes, and two fried in shallow oil 30 minutes, and three fried in shallow oil 15 minutes, three fry in shallow oil and convert about together 1000ml, be concentrated into about 250ml,, perhaps make powdery and mix with Fructus Lycii 15g, Radix Polygoni Multiflori 15g, Fructus Crataegi 15g, Rhizoma Polygonati 15g, Radix Salviae Miltiorrhizae 15g, Rhizoma Alismatis 15g as the dose of a bu three times, be provided with boiling water and brew, in one day for tea-drinking.
The present invention can reach dosage in a manner described and make finished medicines,, does not also get rid of and makes said dosage form on other pharmaceutics for brewing for tea-drinking etc. as the powder of the good drink liquid of fill, packing according to dosage.
[model case]
Case one: Zheng Changsheng, Tangyin County, Henan Province director of Medical Services, 51 years old, height 175cm, He is 1.88 meters tall, and weighs 94 kilograms, blood pressure is about 180/120mmHg.Dizzy, insomnia, sensation of oppression over the chest with shortness of breath, brothers are scorching, honey stomach, and constipation and blood glucose, glucose in urine height, stringy and thready pulse, body of the tongue is dim red.In first visit on April 6 in 1996, laboratory examination: cholesterol 300mg%, beta Lipoprotein 1325mg%, triglyceride 98mg% is diagnosed as hyperlipidemia.Make Antilipemic beverage with the present invention, adhered to continuous use two months, blood pressure drops to 140/95mmHg, and other symptom also alleviates thereupon or eliminates.It is month surplus intermittently to take medicine again, laboratory examination: cholesterol 290mg%, and beta Lipoprotein 460mg%, triglyceride 78mg%, body weight is reduced to 86 kilograms.Advise it to note adjusting daily life, drug withdrawal is chemical examination again after 1 year, cholesterol 180mg%, and beta Lipoprotein 248mg%, triglyceride 65mg%, body weight is reduced to 80 kilograms, and other symptom is also all eliminated.Follow up a case by regular visits to after 3 years, have the constipation, do not have other discomfort except that accidental.
Case two: Shen Yulian, woman, 48 years old, the accounting of Earthquake of Anyang station in Henan material office.Because of edema, numb limbs and tense tendons arrives examination in hospital for many years, and the result is: blood pressure 140/95mgHg, and cholesterol 310mg%, beta Lipoprotein 680mg%, body weight surpasses 8 kilograms, is diagnosed as hyperlipidemia.Antilipemic beverage of the present invention is taken in first visit on October 20 in 1998, check after month: cholesterol 180mg%, and beta Lipoprotein 350mg%, back medication at intermittence two months, numb, edema is eliminated fully, blood pressure 120/75mgHg, body weight is reduced to normally.
Case three: Xiong Xianren, the man, 48 years old, Zhongyuan Oil Field, Puyang cadre, dizziness, insomnia, dreaminess, hypomnesis, tired be stranded pretend 3 years surplus.Blood pressure is more than 150/100mmHg usually, and body weight is fat slightly partially, and once how tame large hospital checked that clinical diagnosis was a hyperlipidemia, and early stage cerebral arteriosclerosis.Result of laboratory test: cholesterol 265mg%, beta Lipoprotein 805mg%, triglyceride 130mg%, check after 1 month through obeying Antilipemic beverage of the present invention: cholesterol 96mg%, blood pressure remain on disease the alleviating of being left on the 120/80mmHg.For consolidating curative effect, continue medication 1 month, all symptoms are eliminated.
This shows that prescription of the present invention has nourishing the liver and kidney, removing blood stasis with potent drugs collateral dredging, blood fat-reducing blood pressure-decreasing, relieving distension effect of weight reducing, can be used for the treatment for the treatment of hyperlipemia and complication thereof clinically, and is respond well.
Claims (4)
1, a kind of Antilipemic beverage is characterized in that it is to get each portion of Fructus Lycii, the Radix Polygoni Multiflori, Fructus Crataegi, Rhizoma Polygonati, Radix Salviae Miltiorrhizae and Rhizoma Alismatis resulting decocting liquid behind decocting.
2, Antilipemic beverage according to claim 1, it is characterized in that described drink liquid is with Fructus Lycii 15g, Radix Polygoni Multiflori 15g, Fructus Crataegi 15g, Rhizoma Polygonati 15g, Radix Salviae Miltiorrhizae 15g and Rhizoma Alismatis 15g, with slow fire decocting three times, one fried in shallow oil 40 minutes, two fried in shallow oil 30 minutes, three fried in shallow oil 15 minutes, and three fry in shallow oil and convert about together 1000ml, were concentrated into about 250ml and obtained.
3, a kind of antihyperlipemic tea is characterized in that it forms by being ground into each a mixing of powdered Fructus Lycii, the Radix Polygoni Multiflori, Fructus Crataegi, Rhizoma Polygonati, Radix Salviae Miltiorrhizae and Rhizoma Alismatis.
4, antihyperlipemic tea according to claim 3 is characterized in that every dose of described antihyperlipemic tea contains Fructus Lycii 15g, Radix Polygoni Multiflori 15g, Fructus Crataegi 15g, Rhizoma Polygonati 15g, Radix Salviae Miltiorrhizae 15g and Rhizoma Alismatis 15g.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN00129714A CN1099835C (en) | 2000-09-29 | 2000-09-29 | Antilipemic beverage or tea |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN00129714A CN1099835C (en) | 2000-09-29 | 2000-09-29 | Antilipemic beverage or tea |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1286924A CN1286924A (en) | 2001-03-14 |
| CN1099835C true CN1099835C (en) | 2003-01-29 |
Family
ID=4593693
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN00129714A Expired - Fee Related CN1099835C (en) | 2000-09-29 | 2000-09-29 | Antilipemic beverage or tea |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1099835C (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1534082A4 (en) * | 2002-08-14 | 2006-05-10 | Bionutrigen Co Ltd | Powder or extracts of plant leaves with anti-obesity effects and anti-obesity food comprising them |
| US7410658B2 (en) * | 2004-12-22 | 2008-08-12 | Avon Products, Inc. | Use of Alisma orientale in cosmetics and compositions thereof |
| CN102389458B (en) * | 2007-08-07 | 2013-08-14 | 北京北大维信生物科技有限公司 | Application of Chinese herbal medicine Radix Salviae Miltiorrhizae extract for preparing anti-obesity and antihyperlipidemic drugs or drugs with lipase activity inhibitory effect |
| CN102613546A (en) * | 2012-03-15 | 2012-08-01 | 黄宏植 | Diet therapy product capable of regulating blood fat and preparation method thereof |
| CN103432391A (en) * | 2013-08-30 | 2013-12-11 | 董中影 | Medicament for treating hyperlipemia and preparation method thereof |
| CN104824286A (en) * | 2015-06-01 | 2015-08-12 | 西宁志培知识产权咨询有限公司 | Preparation method of weight-losing substitutional tea prepared by adopting edible plants as ingredients |
| CN104872324A (en) * | 2015-06-09 | 2015-09-02 | 杨胜 | Weight-losing and body-building tea |
| CN109771565A (en) * | 2017-11-15 | 2019-05-21 | 广西西林县农本生物科技有限公司 | A kind of Chinese medicine composition for treating hyperlipidemia |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1066786A (en) * | 1992-05-15 | 1992-12-09 | 东北第六制药厂二分厂 | The reparation technology of long-life and fat-reducing powder |
-
2000
- 2000-09-29 CN CN00129714A patent/CN1099835C/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1066786A (en) * | 1992-05-15 | 1992-12-09 | 东北第六制药厂二分厂 | The reparation technology of long-life and fat-reducing powder |
Non-Patent Citations (1)
| Title |
|---|
| 中国药茶谱第1版 1995-09-01 卢祥之科学技术文献出版社 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1286924A (en) | 2001-03-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102343023B (en) | Medicinal composition and preparation method and application thereof | |
| CN108578544A (en) | A kind of Chinese medicine composition and the preparation method and application thereof with blood sugar reducing function | |
| CN1099835C (en) | Antilipemic beverage or tea | |
| CN101716241B (en) | Weight-losing and fat-lowering medicinal composition and preparation method thereof | |
| CN102726557A (en) | Food possessing auxiliary hypolipidemic function | |
| CN101427720A (en) | High-concentration infusion tea for treating diabetes and method of producing the same | |
| CN101406602B (en) | Seven-ingredient rehmannia hypoglycemic capsule for treating type II diabetes | |
| CN106109951A (en) | Prevent and treat medicine of hyperglycemia, hyperlipidemia, hypertension and preparation method thereof | |
| CN101843843A (en) | Chinese medicament for treating diabetes | |
| CN1939506B (en) | Preparation with blood-pressure, blood-sugar and blood-fat lowering functions and its making method | |
| CN101007080A (en) | Chinese medicinal preparation for lowering blood fat and benefiting liver | |
| CN116870100A (en) | Traditional Chinese medicine compound composition for treating obesity-related hypertension and preparation method thereof | |
| CN103525640B (en) | Energy-keeping yang-tonifying wine | |
| CN101837104B (en) | Hyperlipidemia treating capsules | |
| CN104288527B (en) | It is a kind of to be used to treat Chinese medicine composition of diabetes and preparation method and application | |
| CN103083590A (en) | Medicine used for treating decompensated liver cirrhosis, and preparation method thereof | |
| CN101549075A (en) | Traditional Chinese medicine composition for treating mammary gland hyperplasia and preparation method thereof | |
| CN101953917B (en) | Chinese medicinal composition for preventing and treating cardiovascular and cerebrovascular diseases and preparation method thereof | |
| CN1850160A (en) | Qidantongmai Tablet, and its preparing process | |
| CN102078562B (en) | Chinese medicinal oral liquid for treating children metabolic syndrome and preparation method thereof | |
| CN100522197C (en) | Chinese-medicinal preparation for treating high blood fat and its making method | |
| CN102397391A (en) | Medicine for treating hypertension, hyperlipemia and blood hyperviscosity and preparation method thereof | |
| CN100381121C (en) | New use of linolenic acid in preparation of anti arthrolithiasis medicine or health care food | |
| CN102068670B (en) | Chinese medicinal composition for treating hyperlipidemia | |
| CN108403803B (en) | A traditional Chinese medicine compound preparation for preventing and treating cardiovascular complications of diabetes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |